NCT00760279View on ClinicalTrials.gov

An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Conditions

UreaplasmaBacterial Infection

Interventions

DRUG

Azithromycin

Trial Locations (2)

48201

Wayne State, Detroit

44106-6010

Rainbow Babies and Children's Hospital, Cleveland

All Listed Sponsors

collaborator

Pediatric Pharmacology Research Units Network

NETWORK

collaborator

Children's Hospital of Michigan

OTHER

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00760279 - An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates | Biotech Hunter | Biotech Hunter